A new study published in the journal Diabetes & Vascular Disease Research has found that oral semaglutide reduces total energy intake and changes in the food preference in patients with type ...

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...

Telehealth company Him & Hers Health is taking a very different approach to its Super Bowl ad this year - as its new ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...